TrialNature communications2025

Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study.

Anja Koester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.